The gene expression levels of DR4 and BDNF were higher in high-frequency rMS treated cells as compared to those not rMS-treated cells in the AD model (Ps < 0.05) (Fig. 5b–d). The gene discussed is TNFRSF10A; the disease is Alzheimer disease.